SCHEMBL30810409

SCHEMBL30810409

O=C(Nc1nc2ccc(C(F)(F)F)cc2s1)c1ccccc1

nearest known ligand 0.73

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 2/20 0.73
CSNK1D P48730 6/20 0.71
DYRK1A Q13627 1/20 0.70
NPC1 O15118 2/20 0.67
RAB9A P51151 2/20 0.67
SMN1; SMN2 Q16637 2/20 0.67
MEN1 O00255 1/20 0.67
KMT2A Q03164 1/20 0.67
SCD O00767 4/20 0.65
CSNK2A2 P19784 1/20 0.64
CSNK2B P67870 1/20 0.64
CSNK2A1 P68400 1/20 0.64
CSNK2A3 Q8NEV1 1/20 0.64
ACP1 P24666 1/20 0.63
TP53 P04637 1/20 0.61
MAPT P10636 1/20 0.61
CYP2D6 P10635 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13762134 0.87 MAP3K5 (0.72) LRRK2DYRK1ANPC1RAB9ASMN1; SMN2
SCHEMBL3791611 0.87 DYRK1A (0.78) LRRK2CSNK1DDYRK1ACSNK2A2CSNK2B
SCHEMBL16992980 0.86 SCD (0.67) LRRK2CSNK1DDYRK1ANPC1RAB9A
SCHEMBL30810297 0.85 MEN1 (0.65) LRRK2CSNK1DDYRK1ANPC1RAB9A
SCHEMBL28615806 0.85 DYRK1A (0.65) LRRK2CSNK1DDYRK1ANPC1RAB9A
SCHEMBL14808404 0.85 DHODH (0.78) LRRK2NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL18375319 0.85 CSNK1D (0.74) CSNK1DDYRK1ANPC1RAB9ASMN1; SMN2
SCHEMBL14808057 0.84 NPC1 (0.76) LRRK2NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL30370064 0.84 LRRK2 (1.00) LRRK2DYRK1ANPC1RAB9ASMN1; SMN2
SCHEMBL10737504 0.84 DYRK1A (0.66) LRRK2CSNK1DDYRK1ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4583870-A2 MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER Mito Biopharma, LLC (US) 2025-07-16 EP disclosed
WO-2024054766-A2 MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER MITO BIOPHARMA, LLC (US) 2024-03-14 WO disclosed